Skip to content

HEMERAD

Active Private limited companyfounded 2023active for 3 yearsRue des Anglais 50, 4000 LiègeKBO/BCE: BE 0797.313.571

Lifetime

3 annual accounts with figures on one time axis
peak of €233,237 in 2025
€233,237▲ 52.3%
peak of €158,133 in 2025
€158,133▲ 62.3%
peak of €412,061 in 2025
€412,061▲ 62.3%
€75,979▼ 62.7%
Board1 name since 2023
1 director
Documentsfilings and deeds
26-08-202626 days late
2025micro format
Gross margin from €153,101 to €233,237Result from €97,440 to €158,133Equity from €253,928 to €412,061Debts from €203,532 to €75,979

Key points

from the 2025 annual accounts

Equity

€412,061 ▲ 62.3%

HEMERAD has made a profit in every financial year since 2023.

Result

€158,133 ▲ 62.3%
€97,4002024€158,0002025

The result rose in 2025 from €97,440 to €158,133.

Turnover

≈ €430,000 estimated

The micro format states no turnover.

Liquidity

9.16 was 2.46 in 2024

Short-term debts fell from €163,590 to €48,334.

Filings

3 annual accounts 3 late
AprilJune31 JulyOctober202320242025

The 2023 accounts came in latest, 27 days after the end of the period.

Position in the sector

€158,133

Higher net result than 82% of companies in human health. The sector median is €59,520, over 21,372 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,138 companies had the same profile as HEMERAD has now. Each dot stands for 8 companies, two years later.

97.0%
were still trading
2.1%
stopped another way
0.9%
went bankrupt
  • Small
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,138 companies, not a prediction for HEMERAD. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 20-01-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0797313571
Incorporation Founding capital of €5,000, 100 shares · Founded by (comparant constituant) · appointed as director · published on 20-01-2023 · Gazette deed
First establishment Rue des Anglais 50, Liège
All 10 events

Comparable companies

same main activity, similar in size and age
Company
HEMERAD Liège €488,041 €233,237 84.4% -
OPHES Liège €442,065 €250,522 77.3% -
SR OPHTALMO Chaudfontaine €466,721 €219,230 94.7% -
LVD Medical Nandrin €460,227 €210,541 80.4% -
Dr. Gerets J. Anesthesie Schilde €487,846 €235,097 86.2% -
Dr. Thomas Beukeleirs Antwerp €491,676 €239,950 83.3% -
Focus Leuven €491,568 €245,502 77.5% -

These companies have the same main activity as HEMERAD: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €442,000 and €492,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 18-01-2023Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.340.758.5674000 Liège, since 18-01-2023
Financial year end
31 December
Peppol
Reachable since 28-12-2025
Company details

Annual accounts 2025

€488,041▲ 6.7%
Filing
Filed on 26-08-2026
Financials

Insights on HEMERAD

HEMERAD files the micro format. That format states no turnover. The gross margin rose from €224,665 in 2023 to €233,237 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about HEMERAD

What is the company number of HEMERAD?
The company number of HEMERAD is 0797.313.571. The VAT number is the same number with BE in front: BE 0797.313.571.
Where is HEMERAD based?
The registered office is at Rue des Anglais 50, 4000 Liège.Company details
What does HEMERAD do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of HEMERAD?
HEMERAD is a private limited company (BV).
When was HEMERAD founded?
HEMERAD was founded on 18-01-2023.
Is HEMERAD still active?
Yes, HEMERAD is an active enterprise in the KBO register.
What is the turnover of HEMERAD?
The turnover in financial year 2025 is about €430,000. This figure is estimated from the gross margin of €233,237 and 40 comparable companies (NACE 86220). It probably lies between €370,000 and €580,000.Financials
Is HEMERAD profitable?
In financial year 2025, HEMERAD made a profit of €158,133.
Where can I find the annual accounts of HEMERAD?
HEMERAD filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of HEMERAD due?
HEMERAD must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.